Clinical trials, genetic add-ons, and the question of benefit-sharing.
| Publicado en: | Lancet Vol. 362; no. 9379; pp. 242 - 245 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Lancet
7/19/2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106656403&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106656403 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 7/19/2003 vid: 362 iid: 9379 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 106656403 106656403 2004170965 NLM12885490 106656403 ppf: 242 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Clinical trials, genetic add-ons, and the question of benefit-sharing. aug: au: Pullman D Latus A affil: Faculty of Medicine, Memorial University of Newfoundland, St John's, NL A1B 3V6, Canada; dpullman@mun.ca sug: subj: Clinical Trials Genetics, Medical Research, Medical Ethical Issues DNA Ethics, Medical Pharmacy and Pharmacology Study Design Tissue Banks pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|